Aug 27, 2026 05:05PM
Aug 25, 2026 07:25AM
Aug 5, 2026 07:25AM
Jul 2, 2026 07:25AM
May 28, 2026 05:05PM
May 13, 2026 07:25AM
Apr 23, 2026 06:00PM Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results
Apr 16, 2026 07:25AM
Mar 17, 2026 07:25AM
Mar 10, 2026 07:25AM
Mar 10, 2026 07:25AM
Feb 20, 2026 07:25AM
Feb 19, 2026 07:25AM
Feb 17, 2026 07:25AM Kane Biotech receives FDA clearance for wound cleanser product
Feb 17, 2026 07:25AM
Feb 12, 2026 07:25AM
Dec 18, 2025 07:25AM
Dec 18, 2025 07:25AM
Dec 17, 2025 07:25AM
Dec 10, 2025 07:25AM
Nov 28, 2025 07:25AM Kane Biotech Announces Third Quarter 2025 Financial Results
Nov 4, 2025 07:25AM
Sep 10, 2025 05:05PM
Sep 4, 2025 08:00AM
Aug 28, 2025 05:05PM
Apr 28, 2025 04:05PM
Nov 28, 2024 04:15PM
Nov 27, 2024 08:30AM Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel
Nov 12, 2024 01:08PM
Aug 29, 2024 04:15PM
Aug 13, 2024 08:30AM
Jul 23, 2024 08:30AM
May 23, 2024 04:15PM
Mar 26, 2024 04:05PM
Mar 8, 2024 09:00AM Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
Feb 22, 2024 08:00AM
Aug 29, 2023 04:29PM
May 25, 2023 04:05PM
May 25, 2023 10:38AM
Apr 20, 2023 04:05PM
Apr 20, 2023 07:30AM
Jan 4, 2023 07:30AM Kane Biotech Announces First Distribution Agreement for its coactiv+™ Antimicrobial Hydrogel
Nov 24, 2022 04:10PM
Nov 3, 2022 07:30AM
Mar 24, 2022 04:05PM
Feb 10, 2022 08:00AM
Jan 20, 2022 12:00PM
Jul 22, 2021 08:00AM
Jul 13, 2021 08:00AM Kane Biotech announces two key milestones as DispersinB® wound care project advances towards human clinical trials
Jan 17, 2019 09:00AM

332,919 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All